Liu X, Xu J, Zhu J, Wang Z, Fang H, Guo W, Cao L, Cheng YY, & Song K. (2026). Multimodal therapy process engineering mediated by 3 D-printed scaffolds for enhanced postoperative osteosarcoma regeneration. Tissue & Cell, 98, 103212-103212. https://doi.org/10.1016/j.tice.2025.103212
ISO-690 (author-date, English)LIU X, XU J, ZHU J, WANG Z, FANG H, GUO W, CAO L, CHENG YY and SONG K, 2026. Multimodal therapy process engineering mediated by 3 D-printed scaffolds for enhanced postoperative osteosarcoma regeneration. Tissue & cell. 1 February 2026. Vol. 98, , p. 103212-103212. DOI 10.1016/j.tice.2025.103212.
Modern Language Association 9th editionLiu X, Xu J, Zhu J, Wang Z, Fang H, Guo W, Cao L, Cheng YY, and Song K. “Multimodal Therapy Process Engineering Mediated by 3 D-Printed Scaffolds for Enhanced Postoperative Osteosarcoma Regeneration.”. Tissue & Cell, vol. 98, Feb. 2026, pp. 103212-, https://doi.org/10.1016/j.tice.2025.103212.
Mohr Siebeck - Recht (Deutsch - Österreich)Liu X/Xu J/Zhu J/Wang Z/Fang H/Guo W et al.: Multimodal therapy process engineering mediated by 3 D-printed scaffolds for enhanced postoperative osteosarcoma regeneration., Tissue & cell 2026, 103212-103212.
Emerald - HarvardLiu X, Xu J, Zhu J, Wang Z, Fang H, Guo W, Cao L, Cheng YY and Song K. (2026), “Multimodal therapy process engineering mediated by 3 D-printed scaffolds for enhanced postoperative osteosarcoma regeneration.”, Tissue & Cell, Vol. 98, pp. 103212-103212.